Development of an oral push–pull osmotic pump of fenofibrate-loaded mesoporous silica nanoparticles

References

• WangFHuiHBarnesTJBarnettCPrestidgeCAOxidized mesoporous silicon microparticles for improved oral delivery of poorly soluble drugsMol Pharm20107122723619874003
   PubMed Web of Science ®Google Scholar
• ChenJFDingHMWangJXShaoLPreparation and characterization of porous hollow silica nanoparticles for drug delivery applicationBiomaterials200425472372714607511
   PubMed Web of Science ®Google Scholar
• ZhaoPJiangHJiangTInclusion of celecoxib into fibrous ordered mesoporous carbon for enhanced oral bioavailability and reduced gastric irritancyEur J Pharm Sci201245563964722251657
   PubMed Web of Science ®Google Scholar
• WangXLiXItoASogoYOhnoTParticle-size-dependent toxicity and immunogenic activity of mesoporous silica-based adjuvants for tumor immunotherapyActa Biomater2013977480748923541601
   PubMed Web of Science ®Google Scholar
• Vallet-RegíMBalasFArcosDMesoporous materials for drug deliveryAngew Chem Int Ed Engl200746407548755817854012
   PubMed Web of Science ®Google Scholar
• HuYZhiZZhaoQ3D cubic mesoporous silica microsphere as a carrier for poorly soluble drug carvedilolMicroporous and Mesoporous Mater2012147194101
   Web of Science ®Google Scholar
• HeQMaMWeiCShiJMesoporous carbon@silicon-silica nano-theranostics for synchronous delivery of insoluble drugs and luminescence imagingBiomaterials201233174392440222425026
   PubMed Web of Science ®Google Scholar
• KilpeläinenMMönkäreJVlasovaMANanostructured porous silicon microparticles enable sustained peptide (Melanotan II) deliveryEur J Pharm Biopharm2011771202520965250
   PubMed Web of Science ®Google Scholar
• FuCLiuTLiLLiuHChenDTangFThe absorption, distribution, excretion and toxicity of mesoporous silica nanoparticles in mice following different exposure routesBiomaterials201334102565257523332175
   PubMed Web of Science ®Google Scholar
• KapoorSHegdeRBhattacharyyaAJInfluence of surface chemistry of mesoporous alumina with wide pore distribution on controlled drug releaseJ Control Release20091401343919654029
   PubMed Web of Science ®Google Scholar
• VialpandoMAertsAPersoonsJMartensJVan Den MooterGEvaluation of ordered mesoporous silica as a carrier for poorly soluble drugs: influence of pressure on the structure and drug releaseJ Pharm Sci201110083411342021387318
   PubMed Web of Science ®Google Scholar
• TabasiOFalamakiCKhalajZFunctionalized mesoporous silicon for targeted-drug-deliveryColloids Surf B Biointerfaces201298182522652355
   PubMed Web of Science ®Google Scholar
• PastorEMatveevaEValle-GallegoAGoycooleaFMGarcia-FuentesMProtein delivery based on uncoated and chitosan-coated mesoporous silicon microparticlesColloids Surf B Biointerfaces201188260160921855304
   PubMed Web of Science ®Google Scholar
• ZhangLChaiGZengXHeHXuHTangXPreparation of fenofibrate immediate-release tablets involving wet grinding for improved bioavailabilityDrug Dev Ind Pharm20103691054106320818965
   PubMed Web of Science ®Google Scholar
• PlusquellecYEfthymiopoulosCDuthilPHouinGA pharmacokinetic model for multiple sites discontinuous gastrointestinal absorptionMed Eng Phys199921852553210672785
   PubMed Web of Science ®Google Scholar
• MertensBCahayBKlinkenbergRStreelBAn automated method for the simultaneous determination of pravastatin, 3-hydroxy isomeric metabolite, pravalactone and fenofibric acid in human plasma by sensitive liquid chromatography combined with diode array and tandem mass spectrometry detectionJ Chromatogr A200811891–249350218342321
   PubMed Web of Science ®Google Scholar
• ChoYDParkYJIn vitro and in vivo evaluation of a self-microemulsifying drug delivery system for the poorly soluble drug fenofibrateArch Pharm Res201437219320323754165
   PubMed Web of Science ®Google Scholar
• VermaRKGargSDevelopment and evaluation of osmotically controlled oral drug delivery system of glipizideEur J Pharm Biopharm200457351352515093601
   PubMed Web of Science ®Google Scholar
• TheeuwesFElementary osmotic pumpJ Pharm Sci19756412198719911510
   PubMed Web of Science ®Google Scholar
• XuWLiNGaoCPreparation of controlled porosity osmotic pump tablets for salvianolic acid and optimization of the formulation using an artificial neural network methodActa Pharmaceutica Sinica B2011116470
   Google Scholar
• HillAGeißlerSWeigandtMMäderKControlled delivery of nanosuspensions from osmotic pumps: zero order and non-zero order kineticsJ Control Release2012158340341222198270
   PubMed Web of Science ®Google Scholar
• EckenhoffBYumSIThe osmotic pump: novel research tool for optimizing drug regimensBiomaterials19812289977248427
   PubMed Web of Science ®Google Scholar
• SathyanGXuEThipphawongJGuptaSKPharmacokinetic investigation of dose proportionality with a 24-hour controlled-release formulation of hydromorphoneBMC Clin Pharmacol20077317270058
   PubMedGoogle Scholar
• TheeuwesFEvolution and design of ‘rate controlled’ osmotic formsCurr Med Res Opin19838Suppl 2S20S27
   PubMedGoogle Scholar
• TheeuwesFYumSIPrinciples of the design and operation of generic osmotic pumps for the delivery of semisolid or liquid drug formulationsAnn Biomed Eng1976443433531020825
   PubMed Web of Science ®Google Scholar
• TahvanainenMRotkoTMäkiläETablet preformulations of indomethacin-loaded mesoporous silicon microparticlesInt J Pharm20124221–212513122063301
   PubMedGoogle Scholar
• NandiyantoABDKimSGIskandarFOkuyamaKSynthesis of spherical mesoporous silica nanoparticles with nanometer-size controllable pores and outer diametersMicroporous and Mesoporous Mater20091203447453
   Web of Science ®Google Scholar
• LiuLXuXPreparation of bilayer-core osmotic pump tablet by coating the indented core tabletInt J Pharm20083521–222523018068918
   PubMedGoogle Scholar
• ZhangXYiYQiJControlled release of cyclosporine A self- nanoemulsifying systems from osmotic pump tablets: near zero-order release and pharmacokinetics in dogsInt J Pharm20134521–223324023688622
   PubMed Web of Science ®Google Scholar
• KiekensFEelenSVerheydenLDaemsTMartensJVan Den MooterGUse of ordered mesoporous silica to enhance the oral bioavailability of ezetimibe in dogsJ Pharm Sci201210131136114422190350
   PubMed Web of Science ®Google Scholar
• NoyesAAWhitneyWRThe rate of solution of solid substances in their own solutionsJ Am Chem Soc18971912930934
   Google Scholar
• BrunerLTolloczkoSÜber die Auflösungsgeschwindigkeit fester Körper [The dissolution rate of solid bodies]Zeitschrift für Anorganische Chemie1901281314330 German
   Google Scholar
• LiuXWangSChaiLA two-step strategy to design high bioavailable controlled-release nimodipine tablets: the push-pull osmotic pump in combination with the micronization/solid dispersion techniquesInt J Pharm20144611–252953924374219
   PubMedGoogle Scholar
• ZhangYWangJBaiXJiangTZhangQWangSMesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugsMol Pharm20129350551322217205
   PubMedGoogle Scholar
• JiaLShenJLiZIn vitro and in vivo evaluation of paclitaxel-loaded mesoporous silica nanoparticles with three pore sizesInt J Pharm20134451–2121923384728
   PubMed Web of Science ®Google Scholar